JEN Stock Analysis: Jenoptik | XETRA
Electronic Components | XETRA, Germany | Market Cap: 2.193m EUR | 12M Return: 107.1% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 8.15M
EPS Trend: 24.4%
Qual. Beats: 1
Rev. Trend: -6.3%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Jenoptik AG is a German photonics company that operates through four main segments: Semiconductor & Advanced Manufacturing, Biophotonics, Metrology & Production Solutions, and Smart Mobility Solutions. Its product portfolio spans imaging systems and cameras, laser technology, optical and microoptical components, optoelectronic systems, and road safety solutions such as speed and red-light enforcement cameras. The company serves a diverse range of end markets, including automotive, defense and security, data communication, medical technology, semiconductor equipment, and public safety. Founded in 1846 and headquartered in Jena, Germany, Jenoptik is classified within the Semiconductor Materials & Equipment sub-industry, reflecting its significant exposure to photonics-enabled manufacturing tools used in semiconductor production processes.
- Semiconductor equipment orders rebound on EUV lithography demand
- Smart Mobility traffic enforcement contracts expand in Europe and US
- Biophotonics margins pressured by Asian competition and pricing
| Net Income: 79.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 1.72 > 1.0 |
| NWC/Revenue: 31.63% < 20% (prev 17.34%; Δ 14.29% < -1%) |
| CFO/TA 0.10 > 3% & CFO 163.5m > Net Income 79.5m |
| Net Debt (375.3m) to EBITDA (202.4m): 1.85 < 3 |
| Current Ratio: 2.29 > 1.5 & < 3 |
| Outstanding Shares: last quarter (57.2m) vs 12m ago -1.25% < -2% |
| Gross Margin: 33.19% > 18% (prev 33.03%; Δ 0.15% > 0.5%) |
| Asset Turnover: 61.56% > 50% (prev 65.50%; Δ -3.94% > 0%) |
| Interest Coverage Ratio: 5.67 > 6 (EBIT TTM 125.3m / Interest Expense TTM 22.1m) |
| A: 0.19 (Total Current Assets 586.1m - Total Current Liabilities 256.1m) / Total Assets 1.71b |
| B: 0.37 (Retained Earnings 633.6m / Total Assets 1.71b) |
| C: 0.07 (EBIT TTM 125.3m / Avg Total Assets 1.70b) |
| D: 1.52 (Book Value of Equity 1.02b / Total Liabilities 675.3m) |
| Altman-Z'' = 4.57 = AA |
| DSRI: 1.16 (Receivables 221.3m/201.3m, Revenue 1.04b/1.10b) |
| GMI: 1.00 (GM 33.03% / 33.19%) |
| AQI: 0.97 (AQ_t 0.41 / AQ_t-1 0.42) |
| SGI: 0.95 (Revenue 1.04b / 1.10b) |
| TATA: -0.05 (NI 79.5m - CFO 163.5m) / TA 1.71b) |
| Beneish M = -2.96 (Cap -4..+1) = A |
As of July 10, 2026, the stock is trading at EUR 40.56 with a total of 160,964 shares traded. Over the past week, the price has changed by -5.45%, over one month by -6.20%, over three months by +37.00% and over the past year by +107.06%.
Current recommended Stop Loss: 38.00 (which is 6.3% or 1.2 ATR below the current price).
Jenoptik has no consensus analysts rating.
P/E Trailing = 28.812
P/E Forward = 16.2602
P/S = 2.1017
P/B = 2.4408
P/EG = 1.1285
Revenue TTM = 1.04b EUR
EBIT TTM = 125.3m EUR
EBITDA TTM = 202.4m EUR
Long Term Debt = 223.7m EUR (from longTermDebt, last fiscal year)
Short Term Debt = 24.5m EUR (from shortTermDebt, last quarter)
Debt = 459.6m EUR (from shortLongTermDebtTotal, last quarter) + Leases 65.3m
Net Debt = 375.3m EUR (calculated: Debt 459.6m - CCE 84.2m)
Enterprise Value = 2.57b EUR (2.19b + Debt 459.6m - CCE 84.2m)
Interest Coverage Ratio = 5.67 (Ebit TTM 125.3m / Interest Expense TTM 22.1m)
EV/FCF = 23.42x (Enterprise Value 2.57b / FCF TTM 109.7m)
FCF Yield = 4.27% (FCF TTM 109.7m / Enterprise Value 2.57b)
FCF Margin = 10.51% (FCF TTM 109.7m / Revenue TTM 1.04b)
Net Margin = 7.62% (Net Income TTM 79.5m / Revenue TTM 1.04b)
Gross Margin = 33.19% ((Revenue TTM 1.04b - Cost of Revenue TTM 697.3m) / Revenue TTM)
Gross Margin QoQ = 35.41% (prev 32.79%)
Tobins Q-Ratio = 1.51 (Enterprise Value 2.57b / Total Assets 1.71b)
Interest Expense / Debt = 4.81% (Interest Expense 22.1m / Debt 459.6m)
Taxrate = 28.86% (31.9m / 110.7m)
NOPAT = 89.2m (EBIT 125.3m * (1 - 28.86%))
Current Ratio = 2.29 (Total Current Assets 586.1m / Total Current Liabilities 256.1m)
Debt / Equity = 0.45 (Debt 459.6m / totalStockholderEquity, last quarter 1.02b)
Debt / EBITDA = 1.85 (Net Debt 375.3m / EBITDA 202.4m)
Debt / FCF = 3.42 (Net Debt 375.3m / FCF TTM 109.7m)
Total Stockholder Equity = 990.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 4.69% (Net Income 79.5m / Total Assets 1.71b)
RoE = 8.03% (Net Income TTM 79.5m / Total Stockholder Equity 990.0m)
RoCE = 10.33% (EBIT 125.3m / Capital Employed (Equity 990.0m + L.T.Debt 223.7m))
RoIC = 6.27% (NOPAT 89.2m / Invested Capital 1.42b)
WACC = 8.77% (E(2.19b)/V(2.65b) * Re(9.89%) + D(459.6m)/V(2.65b) * Rd(4.81%) * (1-Tc(0.29)))
Discount Rate = 9.89% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 29.55 | Cagr: 0.00%
[DCF] Terminal Value 76.62% ; FCFF base≈97.5m ; Y1≈111.8m ; Y5≈164.5m
[DCF] Fair Price = 33.72 (EV 2.31b - Net Debt 375.3m = Equity 1.93b / Shares 57.2m; r=8.77% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 24.44 | EPS CAGR: 2.85% | SUE: 4.0 | # QB: 1
Revenue Correlation: -6.33 | Revenue CAGR: -0.19% | SUE: 0.48 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.39 | Chg30d=+0.00% | Revisions=+0% | Analysts=1
EPS next Quarter (2026-09-30): EPS=0.59 | Chg30d=+0.00% | Revisions=+0% | Analysts=1
EPS current Year (2026-12-31): EPS=1.87 | Chg30d=+2.43% | Revisions=+40% | GrowthEPS=+54.9% | GrowthRev=+8.1%
EPS next Year (2027-12-31): EPS=2.29 | Chg30d=+4.23% | Revisions=+40% | GrowthEPS=+22.6% | GrowthRev=+8.5%
[Analyst] Revisions Ratio: +57% (up=4, down=0)